HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Turgeon, N. A. Articles by Appel, M. C. Search for Related Content PubMed PubMed Citation Articles by Turgeon, N. A. Articles by Appel, M. C.

---

ORIGINAL RESEARCH ARTICLE

Alloimmune Injury and Rejection of Human Skin Grafts on Human Peripheral Blood Lymphocyte–Reconstituted Non-Obese Diabetic Severe Combined Immunodeficient ß₂-Microglobulin-Null Mice

Nicole A. Turgeon^*, Scott J. Banuelos^*, Leonard D. Shultz, Bonnie L. Lyons, Neal Iwakoshi^*, Dale L. Greiner^*, John P. Mordes^*, Aldo A. Rossini^* and Michael C. Appel^*,1

^* University of Massachusetts Medical School, Worcester, Massachussetts 01605 and
The Jackson Laboratory, Bar Harbor, Maine 04609

Small animal models with the capacity to support engraftment of a functional human immune system are needed to facilitate studies of human alloimmunity. In the present investigation, non-obese diabetic (NOD) severe combined immunodeficient (scid) ß₂-microglobulin-null (B2m^null) mice engrafted with human peripheral blood lymphocytes (hu-PBL-NOD-scid B2m^null mice) were used as in vivo models for studying human skin allograft rejection. Hu-PBL-NOD-scid B2m^null mice were established by injection of human spleen cells or PBLs and transplanted with full-thickness allogeneic human skin. Human cell engraftment was enhanced by injection of anti-mouse CD122 antibody. The respective contributions of human CD4⁺ and CD8⁺ cells in allograft rejection were determined using depleting antibodies. Human skin grafts on unmanipulated NOD-scid B2m^null mice uniformly survived but on chimeric hu-PBL-NOD-scid B2m^null mice exhibited severe immune-mediated injury that often progressed to complete rejection. The alloaggressive hu-PBLs did not require prior in vitro sensitization to elicit targeted effector cell activity. Extensive mononuclear cell infiltration directed towards human-origin endothelium was associated with thrombosis and fibrin necrosis. No evidence of graft-versus-host disease was detected. Either CD4⁺ or CD8⁺ T cells may mediate injury and alloimmune rejection of human skin grafts on hu-PBL-NOD-scid B2m^null mice. It is proposed that Hu-PBL-NOD-scid B2m^null mice engrafted with human skin will provide a useful model for analysis of interventions designed to modulate human allograft rejection.

Key Words: hu-PBL-scid • skin allograft • graft rejection • transplantation